Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people ...

With that in mind, Medscape Medical News asked leading primary care physicians for their advice and insight on navigating the ...

Virtual pulmonary rehabilitation is a safe, effective alternative to traditional pulmonary rehabilitation programs for people ...

Treatment can help symptoms and slow disease progression. Chronic obstructive pulmonary disease, commonly referred to as COPD, is a group of progressive lung diseases. An estimated 32 million ...

Results of a large, global clinical trial spanning five continents with over 1,700 patients with bronchiectasis, published ...

Researchers have developed a novel rat model that closely replicates the pathological features and physiological changes ...

GSK has highlighted approval of Nucala in COPD as one of its top 2025 priorities, adding to its established medicines for the ...

How much did they smoke? Were they exposed to smoke from others? Were they born prematurely? Did they experience a lot of ...

If you have chronic obstructive pulmonary disease (COPD), your airways may be inflamed. It may be hard to take deep breaths and get enough oxygen.

The replicate confirmatory KALOS and LOGOS trials evaluated BGF in participants with severe asthma inadequately controlled with standard of care.

AstraZeneca's Breztri met primary goals in four asthma trials, including KALOS, LOGOS, LITHOS, and VATHOS, involving over ...

Phase III trial data published in The New England Journal of Medicine support Nucala’s role as an add-on biologic therapy to ...